Depression Clinical Trials in Houston, TX

51 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
ALTO-207 in Adults With Treatment-resistant Depression (TRD)	Phase 2	Alto Neuroscience	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	<1 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users	N/A	Baylor College of Medicine	<1 mi
Deep Brain Stimulation of Treatment-Resistant Bipolar Depression	N/A	Wayne Goodman MD	<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	<1 mi
Transcutaneous Vagus Nerve Stimulation for Attention and Memory	N/A	Baylor College of Medicine	<1 mi
DBS for Depression	N/A	Baylor College of Medicine	<1 mi
Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder	N/A	The University of Texas Health Science Center, Houston	<1 mi
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression	N/A	VA Office of Research and Development	<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder	Phase 3	Janssen Research & Development, LLC	<1 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
Leveraging Adult Protective Service Interaction to Offer Evidence-Based Treatment for Depression in Elder Neglect/Self Neglect	N/A	The University of Texas Health Science Center, Houston	<1 mi
Improving Adult Protective Services Client Outcomes: A Stepped-Care Social and Mental Health Engagement Program	N/A	The University of Texas Health Science Center, Houston	<1 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)	Phase 2	Alto Neuroscience	<1 mi
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia	N/A	GrayMatters Health Ltd.	<1 mi
Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression	Phase 1	The University of Texas Health Science Center, Houston	<1 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Phase 2	ACADIA Pharmaceuticals Inc.	<1 mi
Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors	N/A	The University of Texas Health Science Center, Houston	<1 mi
Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing	N/A	Baylor College of Medicine	<1 mi
Telehealth Behavioral Activation for Teens	N/A	Baylor College of Medicine	<1 mi
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression	Phase 1	Texas A&M University	<1 mi
Intracranial Investigation of Neural Circuity Underlying Human Mood	N/A	Baylor College of Medicine	<1 mi
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia	N/A	The University of Texas Health Science Center, Houston	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression	N/A	The University of Texas Health Science Center, Houston	<1 mi
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)	N/A	Baylor College of Medicine	<1 mi
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality	Phase 2	The University of Texas Health Science Center, Houston	<1 mi
Improving Behavioral Health for Caregivers and Children After Pediatric Injury	N/A	Medical University of South Carolina	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)	N/A	Joao L. DeQuevedo	<1 mi
Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus	N/A	Christina Chianis Reed	<1 mi
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy	Phase 2	M.D. Anderson Cancer Center	<1 mi
Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story	—	Baylor College of Medicine	<1 mi
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors	Phase 2	M.D. Anderson Cancer Center	<1 mi
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer	Phase 2/3	M.D. Anderson Cancer Center	<1 mi
Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity	N/A	Deliberate Solutions Inc.	<1 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	7 mi
The OBSERVE Protocol	—	Yale University	7 mi
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study	Phase 3	Yale University	7 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	7 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	14 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	19 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	20 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	20 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.